Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hudecek

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|February 16, 2026
Tailored strategies for improved control of CAR-T cells in multiple myelomaAnna Bielowski, Teresa Kilian, Sarah Vera-Cruz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemiaTetsuya Nishida, Michael Hudecek, Ana Kostic, et al.
Cancers|July 27, 2024
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor ImmunityNgoc Thien Thu Nguyen, Rasmus Müller, Daria Briukhovetska, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2018
Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell PlatformJulian Rydzek, Thomas Nerreter, Haiyong Peng, et al.
Haematologica|December 2, 2017
Expression of programmed death-1 on lymphocytes in myeloma patients is lowered during lenalidomide maintenanceSophia Danhof, Martin Schreder, Stefan Knop, et al.
Cancer Immunology, Immunotherapy : CII|April 13, 2023
Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathwayJonas Althaus, Verena Nilius-Eliliwi, Abdelouahid Maghnouj, et al.
Advanced Drug Delivery Reviews|April 2, 2021
Immunocompetent cancer-on-chip models to assess immuno-oncology therapyTengku Ibrahim Maulana, Elena Kromidas, Lars Wallstabe, et al.
International Journal of Molecular Sciences|January 8, 2025
Current Non-Viral-Based Strategies to Manufacture CAR-T CellsLeon Gehrke, Vasco Dos Reis Gonçalves, Dominik Andrae, et al.
Frontiers in Immunology|October 6, 2023
Learning from the microbes: exploiting the microbiome to enforce T cell immunotherapySarah Staudt, Kai Ziegler-Martin, Alexander Visekruna, et al.
Blood|May 7, 2017
Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumabEstefanía García-Guerrero, Tea Gogishvili, Sophia Danhof, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|February 16, 2026
Tailored strategies for improved control of CAR-T cells in multiple myelomaAnna Bielowski, Teresa Kilian, Sarah Vera-Cruz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemiaTetsuya Nishida, Michael Hudecek, Ana Kostic, et al.
Cancers|July 27, 2024
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor ImmunityNgoc Thien Thu Nguyen, Rasmus Müller, Daria Briukhovetska, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2018
Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell PlatformJulian Rydzek, Thomas Nerreter, Haiyong Peng, et al.
Haematologica|December 2, 2017
Expression of programmed death-1 on lymphocytes in myeloma patients is lowered during lenalidomide maintenanceSophia Danhof, Martin Schreder, Stefan Knop, et al.
Cancer Immunology, Immunotherapy : CII|April 13, 2023
Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathwayJonas Althaus, Verena Nilius-Eliliwi, Abdelouahid Maghnouj, et al.
Advanced Drug Delivery Reviews|April 2, 2021
Immunocompetent cancer-on-chip models to assess immuno-oncology therapyTengku Ibrahim Maulana, Elena Kromidas, Lars Wallstabe, et al.
International Journal of Molecular Sciences|January 8, 2025
Current Non-Viral-Based Strategies to Manufacture CAR-T CellsLeon Gehrke, Vasco Dos Reis Gonçalves, Dominik Andrae, et al.
Frontiers in Immunology|October 6, 2023
Learning from the microbes: exploiting the microbiome to enforce T cell immunotherapySarah Staudt, Kai Ziegler-Martin, Alexander Visekruna, et al.
Blood|May 7, 2017
Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumabEstefanía García-Guerrero, Tea Gogishvili, Sophia Danhof, et al.
Pageof 14